Endophenotypes of obsessive–compulsive disorder: rationale, evidence and future potential

References

• Robins LN, Helzer JE, Weissman MM et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch. Gen. Psychiatry41(10), 949–958 (1984).
   PubMed Web of Science ®Google Scholar
• Weissman MM, Bland RC, Canino GJ et al. The cross national epidemiology of obsessive compulsive disorder: the Cross National Collaborative Group. J. Clin. Psychiatry (55 Suppl.), 5–10 (1994).
   PubMedGoogle Scholar
• Diagnostic and Statistical Manual Fourth Edition DSM-IV-TR American Psychiatric Association, VA, USA (2000)
   Google Scholar
• Mataix-Cols D, Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive–compulsive disorder. Am. J. Psychiatry162(2), 228–238 (2005).
   PubMed Web of Science ®Google Scholar
• Baer L. Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J. Clin. Psychiatry55(Suppl.), 18–23 (1994).
   PubMed Web of Science ®Google Scholar
• Denys D, de Geus F, van Megen HJ, Westenberg HG. Symptom dimensions in obsessive–compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure. Psychopathology37(4), 181–189 (2004).
   PubMedGoogle Scholar
• Hasler G, Kazuba D, Murphy DL. Factor analysis of obsessive–compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(4), 403–408 (2006).
   Google Scholar
• Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive–compulsive disorder. Am. J. Psychiatry165(12), 1532–1542 (2008).
   PubMed Web of Science ®Google Scholar
• DuPont RL, Rice DP, Shiraki S, Rowland CR. Economic costs of obsessive–compulsive disorder. Med. Interface8(4), 102–109 (1995).
   PubMedGoogle Scholar
• Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neurosci. Biobehav. Rev.29(3), 399–419 (2005).
   PubMed Web of Science ®Google Scholar
• Carey G, Gottesman I. Twin and family studies of anxiety, phobic, and obsessive disorders. In: Anxiety: New Research and Changing Concepts. Klien DF, Rabkin J (Eds). Raven Press NY, USA 117–136 (1981).
   Google Scholar
• Inoue K, Lupski JR. Genetics and genomics of behavioral and psychiatric disorders. Curr. Opin. Genet. Dev.13(3), 303–309 (2003).
   PubMed Web of Science ®Google Scholar
• Hudziak JJ, Van Beijsterveldt CE, Althoff RR et al. Genetic and environmental contributions to the Child Behavior Checklist Obsessive–Compulsive Scale: a cross-cultural twin study. Arch. Gen. Psychiatry61(6), 608–616 (2004).
   PubMed Web of Science ®Google Scholar
• van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive–compulsive disorder: a review. Twin. Res. Hum. Genet.8(5), 450–458 (2005).
   PubMed Web of Science ®Google Scholar
• van Grootheest DS, Bartels M, Cath DC et al. Genetic and environmental contributions underlying stability in childhood obsessive–compulsive behavior. Biol. Psychiatry61(3), 308–315 (2007).
   PubMed Web of Science ®Google Scholar
• Pauls DL, Alsobrook JP 2nd, Goodman W, Rasmussen S, Leckman JF. A family study of obsessive–compulsive disorder. Am. J. Psychiatry152(1), 76–84 (1995).
   PubMed Web of Science ®Google Scholar
• do Rosario-Campos MC, Leckman JF, Curi M et al. A family study of early-onset obsessive–compulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.136B(1), 92–97 (2005).
   PubMed Web of Science ®Google Scholar
• Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry158(10), 1568–1578 (2001).
   PubMed Web of Science ®Google Scholar
• Nestadt G, Samuels J, Riddle M et al. A family study of obsessive–compulsive disorder. Arch. Gen. Psychiatry57(4), 358–363 (2000).
   PubMed Web of Science ®Google Scholar
• Pauls DL. The genetics of obsessive compulsive disorder: a review of the evidence. Am. J. Med. Genet. C Semin. Med. Genet.148(2), 133–139 (2008).
   Web of Science ®Google Scholar
• Hanna GL, Veenstra-VanderWeele J, Cox NJ et al. Genome-wide linkage analysis of families with obsessive–compulsive disorder ascertained through pediatric probands. Am. J. Med. Genet.114(5), 541–552 (2002).
   PubMed Web of Science ®Google Scholar
• Willour VL, Yao Shugart Y, Samuels J et al. Replication study supports evidence for linkage to 9p24 in obsessive–compulsive disorder. Am. J. Hum. Genet.75(3), 508–513 (2004).
   PubMed Web of Science ®Google Scholar
• Shugart YY, Samuels J, Willour VL et al. Genomewide linkage scan for obsessive–compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol. Psychiatry11(8), 763–770 (2006).
   PubMed Web of Science ®Google Scholar
• Hemmings SM, Stein DJ. The current status of association studies in obsessive–compulsive disorder. Psychiatr. Clin. North Am.29(2), 411–444 (2006).
   PubMed Web of Science ®Google Scholar
• Bloch MH, Landeros-Weisenberger A, Sen S et al. Association of the serotonin transporter polymorphism and obsessive–compulsive disorder: systematic review. Am. J. Med. Genet. B. Neuropsychiatr. Genet.147B(6), 850–858 (2008).
   PubMed Web of Science ®Google Scholar
• Alonso P, Gratacos M, Menchon JM et al. Extensive genotyping of the BDNF and NTRK2 genes define proective haplotypes against obsessive–compulsive disorder. Biol. Psychiatry63(6), 619–628 (2008).
   PubMed Web of Science ®Google Scholar
• Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive–compulsive disorder. Arch. Gen. Psychiatry63(7), 769–776 (2006).
   PubMed Web of Science ®Google Scholar
• Stewart SE, Fagerness JA, Platko J et al. Association of the SLC1A1 glutamate transporter gene and obsessive–compulsive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.144B(8), 1027–1033 (2007).
   PubMed Web of Science ®Google Scholar
• Dickel DE, Veenstra-VanderWeele J, Cox NJ et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive–compulsive disorder. Arch. Gen. Psychiatry63(7), 778–785 (2006).
   PubMed Web of Science ®Google Scholar
• Grados MA, Walkup J, Walford S. Genetics of obsessive–compulsive disorders: new findings and challenges. Brain Dev.25(Suppl. 1), S55–S61 (2003).
   PubMedGoogle Scholar
• Riordan JR, Rommens JM, Kerem B et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science245(4922), 1066–1073 (1989).
   PubMed Web of Science ®Google Scholar
• Bear CE, Li CH, Kartner N et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell68(4), 809–818 (1992).
   PubMed Web of Science ®Google Scholar
• Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N. Engl. J. Med.352(19), 1992–2001 (2005).
   PubMed Web of Science ®Google Scholar
• Ratjen F, Doring G. Cystic fibrosis. Lancet361(9358), 681–689 (2003).
   PubMed Web of Science ®Google Scholar
• Mayer-Hamblett N, Ramsey BW, Kronmal RA. Advancing outcome measures for the new era of drug development in cystic fibrosis. Proc. Am. Thorac. Soc.4(4), 370–377 (2007).
   PubMedGoogle Scholar
• Insel TR, Collins FS. Psychiatry in the genomics era. Am. J. Psychiatry160(4), 616–620 (2003).
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Muller U, Robbins TW, Sahakian BJ. Neuropharmacological modulation of cognition. Curr. Opin. Neurol.19(6), 607–712 (2006).
   PubMedGoogle Scholar
• Chamberlain SR, Sahakian B. Neuropsychological assessment of mood disorder. Clin. Neuropsych. Journ. Treat. Eval.2(3), 137–148 (2005).
   Google Scholar
• Chamberlain SR, Sahakian BJ. The neuropsychiatry of impulsivity. Curr. Opin. Psychiatry20(3), 255–261 (2007).
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Sahakian BJ. The neuropsychology of mood disorders. Curr. Psychiatry Rep.8(6), 458–463 (2006).
   PubMedGoogle Scholar
• Thompson PM, Cannon TD, Narr KL et al. Genetic influences on brain structure. Nat. Neurosci.4(12), 1253–1258 (2001).
   PubMed Web of Science ®Google Scholar
• Toga AW, Thompson PM. Genetics of brain structure and intelligence. Annu. Rev. Neurosci.28, 1–23 (2005).
   PubMed Web of Science ®Google Scholar
• Wright IC, Sham P, Murray RM, Weinberger DR, Bullmore ET. Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage17(1), 256–271 (2002).
   PubMed Web of Science ®Google Scholar
• John B, Lewis KR. Chromosome variability and geographic distribution in insects. Science152, 711–721 (1966).
   PubMed Web of Science ®Google Scholar
• Gottesman II, Shields J. A polygenic theory of schizophrenia. Proc. Natl Acad. Sci. USA58(1), 199–205 (1967).
   PubMed Web of Science ®Google Scholar
• Gottesman II, Shields J. Genetic theorizing and schizophrenia. Br. J. Psychiatry122(566), 15–30 (1973).
   PubMed Web of Science ®Google Scholar
• Burmeister M, McInnis MG, Zollner S. Psychiatric genetics: progress amid controversy. Nat. Rev. Genet.9(7), 527–540 (2008).
   PubMed Web of Science ®Google Scholar
• Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry160(4), 636–645 (2003).
   PubMed Web of Science ®Google Scholar
• Bearden CE, Freimer NB. Endophenotypes for psychiatric disorders: ready for primetime?. Trends Genet.22(6), 306–313 (2006).
   PubMed Web of Science ®Google Scholar
• Oh G, Petronis A. Environmental studies of schizophrenia through the prism of epigenetics. Schizophr. Bull.34(6), 1122–1129 (2008).
   PubMed Web of Science ®Google Scholar
• Ho BC, Epping E, Wang K et al. Basic helix–loop–helix transcription factor NEUROG1 and schizophrenia: effects on illness susceptibility, MRI brain morphometry and cognitive abilities. Schizophr. Res.106(2–3), 192–199 (2008).
   PubMedGoogle Scholar
• Flint J, Munafo MR. The endophenotype concept in psychiatric genetics. Psychol. Med.37(2), 163–180 (2007).
   PubMed Web of Science ®Google Scholar
• Keating M, Atkinson D, Dunn C et al. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science252(5006), 704–706 (1991).
   PubMed Web of Science ®Google Scholar
• Keating MT, Sanguinetti MC. Molecular and cellular mechanisms of cardiac arrhythmias. Cell104(4), 569–580 (2001).
   PubMed Web of Science ®Google Scholar
• Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N. Engl. J. Med.327(12), 846–852 (1992).
   PubMed Web of Science ®Google Scholar
• Roy N, Kahlem P, Dausse E et al. Exclusion of HRAS from long QT locus. Nat. Genet.8(2), 113–114 (1994).
   PubMedGoogle Scholar
• Wang Q, Curran ME, Splawski I et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet.12(1), 17–23 (1996).
   PubMed Web of Science ®Google Scholar
• Palmer LJ, Burton PR, James AL, Musk AW, Cookson WO. Familial aggregation and heritability of asthma-associated quantitative traits in a population-based sample of nuclear families. Eur. J. Hum. Genet.8(11), 853–860 (2000).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Leaves NI, Anderson GG et al. Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat. Genet.34(2), 181–186 (2003).
   PubMed Web of Science ®Google Scholar
• Anderson GG, Leaves NI, Bhattacharyya S et al. Positive association to IgE levels and a physical map of the 13q14 atopy locus. Eur. J. Hum. Genet.10(4), 266–270 (2002).
   PubMedGoogle Scholar
• Greenwood TA, Braff DL, Light GA et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch. Gen. Psychiatry64(11), 1242–1250 (2007).
   PubMed Web of Science ®Google Scholar
• Dick DM, Jones K, Saccone N et al. Endophenotypes successfully lead to gene identification: results from the collaborative study on the genetics of alcoholism. Behav. Genet.36(1), 112–126 (2006).
   PubMed Web of Science ®Google Scholar
• Beatty J, Laughlin RE. Genomic regulation of natural variation in cortical and noncortical brain volume. BMC Neurosci.7, 16 (2006).
   PubMedGoogle Scholar
• Bearden CE, Reus VI, Freimer NB. Why genetic investigation of psychiatric disorders is so difficult. Curr. Opin. Genet. Dev.14(3), 280–286 (2004).
   PubMedGoogle Scholar
• Siegel C, Waldo M, Mizner G, Adler LE, Freedman R. Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch. Gen. Psychiatry41(6), 607–612 (1984).
   PubMed Web of Science ®Google Scholar
• Freedman R, Coon H, Myles-Worsley M et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl Acad. Sci. USA94(2), 587–592 (1997).
   PubMed Web of Science ®Google Scholar
• Olincy A, Harris JG, Johnson LL et al. Proof-of-concept trial of an a7 nicotinic agonist in schizophrenia. Arch. Gen. Psychiatry63(6), 630–638 (2006).
   PubMed Web of Science ®Google Scholar
• Edenberg HJ, Dick DM, Xuei X et al. Variations in GABRA2, encoding the a2 subunit of the GABA(A) receptor, are associated with alcohol dependence and with brain oscillations. Am. J. Hum. Genet.74(4), 705–714 (2004).
   PubMed Web of Science ®Google Scholar
• Wang JC, Hinrichs AL, Stock H et al. Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum. Mol. Genet.13(17), 1903–1911 (2004).
   PubMed Web of Science ®Google Scholar
• Breiter HC, Rauch SL. Functional MRI and the study of OCD: from symptom provocation to cognitive–behavioral probes of cortico-striatal systems and the amygdala. Neuroimage4(3 Pt 3), S127–S138 (1996).
   PubMed Web of Science ®Google Scholar
• Evans DW, Lewis MD, Iobst E. The role of the orbitofrontal cortex in normally developing compulsive-like behaviors and obsessive–compulsive disorder. Brain Cogn.55(1), 220–234 (2004).
   PubMed Web of Science ®Google Scholar
• Friedlander L, Desrocher M. Neuroimaging studies of obsessive–compulsive disorder in adults and children. Clin. Psychol. Rev.26(1), 32–49 (2006).
   PubMed Web of Science ®Google Scholar
• Greisberg S, McKay D. Neuropsychology of obsessive–compulsive disorder: a review and treatment implications. Clin. Psychol. Rev.23(1), 95–117 (2003).
   PubMed Web of Science ®Google Scholar
• Jenike MA. An update on obsessive–compulsive disorder. Bull. Menninger Clin.65(1), 4–25 (2001).
   PubMedGoogle Scholar
• Kuelz AK, Hohagen F, Voderholzer U. Neuropsychological performance in obsessive–compulsive disorder: a critical review. Biol. Psychol.65(3), 185–236 (2004).
   PubMed Web of Science ®Google Scholar
• Saxena S, Bota RG, Brody AL. Brain–behavior relationships in obsessive–compulsive disorder. Semin. Clin. Neuropsychiatry6(2), 82–101 (2001).
   PubMedGoogle Scholar
• Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive–compulsive disorder. Br. J. Psychiatry35(Suppl.), 26–37 (1998).
   Google Scholar
• Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive–compulsive disorder. Psychiatry Res.132(1), 69–79 (2004).
   PubMed Web of Science ®Google Scholar
• Fontenelle LF, Mendlowicz MV, Paulo M, Marcio V. Neuropsychological findings in obsessive–compulsive disorder and its potential implications for treatment. Curr. Psychiatry Rep.2(1), 11–26 (2006).
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry59(Suppl. 20), 22–33; quiz 34–57 (1998).
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. Motor inhibition and cognitive flexibility in obsessive–compulsive disorder and trichotillomania. Am. J. Psychiatry163(7), 1282–1284 (2006).
   PubMed Web of Science ®Google Scholar
• Aron AR, Durston S, Eagle DM et al. Converging evidence for a fronto–basal-ganglia network for inhibitory control of action and cognition. J. Neurosci.27(44), 11860–11864 (2007).
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Del Campo N, Dowson J et al. Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biol. Psychiatry62, 977–984 (2007).
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Muller U, Blackwell AD et al. Neurochemical modulation of response inhibition and probabilistic learning in humans. Science311(5762), 861–863 (2006).
   PubMed Web of Science ®Google Scholar
• Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat. Neurosci.6(2), 115–116 (2003).
   PubMed Web of Science ®Google Scholar
• Sawle GV, Hymas NF, Lees AJ, Frackowiak RS. Obsessional slowness. Functional studies with positron emission tomography. Brain114(Pt 5), 2191–2202 (1991).
   PubMed Web of Science ®Google Scholar
• Baxter LR Jr, Phelps ME, Mazziotta JC et al. Local cerebral glucose metabolic rates in obsessive–compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch. Gen. Psychiatry44(3), 211–218 (1987).
   PubMed Web of Science ®Google Scholar
• Baxter LR Jr, Schwartz JM, Mazziotta JC et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive–compulsive disorder. Am. J. Psychiatry145(12), 1560–1563 (1988).
   PubMed Web of Science ®Google Scholar
• Nordahl TE, Benkelfat C, Semple WE et al. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology2(1), 23–28 (1989).
   PubMed Web of Science ®Google Scholar
• Swedo SE, Schapiro MB, Grady CL et al. Cerebral glucose metabolism in childhood-onset obsessive–compulsive disorder. Arch. Gen. Psychiatry46(6), 518–523 (1989).
   PubMed Web of Science ®Google Scholar
• McGuire PK, Bench CJ, Frith CD et al. Functional anatomy of obsessive–compulsive phenomena. Br. J. Psychiatry164(4), 459–468 (1994).
   PubMed Web of Science ®Google Scholar
• Rauch SL, Jenike MA, Alpert NM et al. Regional cerebral blood flow measured during symptom provocation in obsessive–compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch. Gen. Psychiatry51(1), 62–70 (1994).
   PubMed Web of Science ®Google Scholar
• Cottraux J, Gerard D, Cinotti L et al. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive–compulsive disorder with checking rituals. Psychiatry Res.60(2–3), 101–112 (1996).
   PubMed Web of Science ®Google Scholar
• Aylward EH, Harris GJ, Hoehn-Saric R et al. Normal caudate nucleus in obsessive–compulsive disorder assessed by quantitative neuroimaging. Arch. Gen. Psychiatry53(7), 577–584 (1996).
   PubMedGoogle Scholar
• Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci.9, 357–381 (1986).
   PubMed Web of Science ®Google Scholar
• Lawrence AD, Sahakian BJ, Robbins TW. Cognitive functions and corticostriatal circuits: insights from Huntington’s disease. Trends Cogn. Sci.2(10), 379–388 (1998).
   PubMedGoogle Scholar
• Saxena S. Neuroimaging and the pathophysiology of obsessive–compulsive disorder (OCD). In: Neuroimaging in Psychiatry. Fu C, Senior C, Russell T, Weinberger D, Murray R (Eds). Martin Dunitz, UK (2003)
   Google Scholar
• Szeszko PR, Robinson D, Alvir JM et al. Orbital frontal and amygdala volume reductions in obsessive–compulsive disorder. Arch. Gen. Psychiatry56(10), 913–919 (1999).
   PubMed Web of Science ®Google Scholar
• Choi JS, Kang DH, Kim JJ et al. Left anterior subregion of orbitofrontal cortex volume reduction and impaired organizational strategies in obsessive–compulsive disorder. J. Psychiatr. Res.38(2), 193–199 (2004).
   PubMed Web of Science ®Google Scholar
• Kang DH, Kim JJ, Choi JS et al. Volumetric investigation of the frontal–subcortical circuitry in patients with obsessive–compulsive disorder. J. Neuropsychiatry. Clin. Neurosci.16(3), 342–349 (2004).
   PubMed Web of Science ®Google Scholar
• Atmaca M, Yildirim BH, Ozdemir BH et al. Volumetric MRI assessment of brain regions in patients with refractory obsessive–compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry30(6), 1051–1057 (2006).
   PubMed Web of Science ®Google Scholar
• Atmaca M, Yildirim H, Ozdemir H, Tezcan E, Poyraz AK. Volumetric MRI study of key brain regions implicated in obsessive–compulsive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry31(1), 46–52 (2007).
   PubMed Web of Science ®Google Scholar
• Robinson D, Wu H, Munne RA et al. Reduced caudate nucleus volume in obsessive–compulsive disorder. Arch. Gen. Psychiatry52(5), 393–398 (1995).
   PubMed Web of Science ®Google Scholar
• Rosenberg DR, Keshavan MS, O’Hearn KM et al. Frontostriatal measurement in treatment-naive children with obsessive–compulsive disorder. Arch. Gen. Psychiatry54(9), 824–830 (1997).
   PubMed Web of Science ®Google Scholar
• Szeszko PR, MacMillan S, McMeniman M et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive–compulsive disorder. Am. J. Psychiatry161(6), 1049–1056 (2004).
   PubMed Web of Science ®Google Scholar
• Scarone S, Colombo C, Livian S et al. Increased right caudate nucleus size in obsessive–compulsive disorder: detection with magnetic resonance imaging. Psychiatry Res.45(2), 115–121 (1992).
   PubMed Web of Science ®Google Scholar
• Valente AA Jr, Miguel EC, Castro CC et al. Regional gray matter abnormalities in obsessive–compulsive disorder: a voxel-based morphometry study. Biol. Psychiatry58(6), 479–487 (2005).
   PubMed Web of Science ®Google Scholar
• Kim JJ, Lee MC, Kim J et al. Gray matter abnormalities in obsessive–compulsive disorder: statistical parametric mapping of segmented magnetic resonance images. Br. J. Psychiatry179, 330–334 (2001).
   PubMed Web of Science ®Google Scholar
• Pujol J, Soriano-Mas C, Alonso P et al. Mapping structural brain alterations in obsessive–compulsive disorder. Arch. Gen. Psychiatry61(7), 720–730 (2004).
   PubMed Web of Science ®Google Scholar
• van den Heuvel OA, Remijnse PL, Mataix-Cols D et al. The major symptom dimensions of obsessive–compulsive disorder are mediated by partially distinct neural systems. Brain132(4), 853–868 (2008).
   PubMedGoogle Scholar
• Remijnse PL, Nielen MM, van Balkom AJ et al. Reduced orbitofrontal–striatal activity on a reversal learning task in obsessive–compulsive disorder. Arch. Gen. Psychiatry63(11), 1225–1236 (2006).
   PubMed Web of Science ®Google Scholar
• van den Heuvel OA, Veltman DJ, Groenewegen HJ et al. Frontal-striatal dysfunction during planning in obsessive–compulsive disorder. Arch. Gen. Psychiatry62(3), 301–309 (2005).
   PubMed Web of Science ®Google Scholar
• Maltby N, Tolin DF, Worhunsky P, O’Keefe TM, Kiehl KA. Dysfunctional action monitoring hyperactivates frontal–striatal circuits in obsessive–compulsive disorder: an event-related fMRI study. Neuroimage24(2), 495–503 (2005).
   PubMed Web of Science ®Google Scholar
• Laird AR, Fox PM, Price CJ et al. ALE meta-analysis: controlling the false discovery rate and performing statistical contrasts. Hum. Brain Mapp.25(1), 155–164 (2005).
   PubMed Web of Science ®Google Scholar
• Menzies L, Chamberlain SR, Laird AR et al. Integrating evidence from neuroimaging and neuropsychological studies of obsessive–compulsive disorder: The orbitofronto–striatal model revisited. Neurosci. Biobehav. Rev.32(3), 525–549 (2008).
   PubMed Web of Science ®Google Scholar
• Soriano-Mas C, Pujol J, Alonso P et al. Identifying patients with obsessive–compulsive disorder using whole-brain anatomy. Neuroimage35(3), 1028–1037 (2007).
   PubMed Web of Science ®Google Scholar
• Harrison BJ, Yucel M, Shaw M et al. Evaluating brain activity in obsessive–compulsive disorder: preliminary insights from a multivariate analysis. Psychiatry Res.147(2–3), 227–231 (2006).
   PubMedGoogle Scholar
• McIntosh AR, Bookstein FL, Haxby JV, Grady CL. Spatial pattern analysis of functional brain images using partial least squares. Neuroimage3(3 Pt 1), 143–157 (1996).
   PubMed Web of Science ®Google Scholar
• McIntosh AR, Lobaugh NJ. Partial least squares analysis of neuroimaging data: applications and advances. Neuroimage23(Suppl. 1), S250–S263 (2004).
   PubMed Web of Science ®Google Scholar
• Menzies L, Achard S, Chamberlain SR et al. Neurocognitive endophenotypes of obsessive–compulsive disorder. Brain130(Pt 12), 3223–3236 (2007).
   PubMed Web of Science ®Google Scholar
• Gould TD, Gottesman II. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav.5(2), 113–119 (2005).
   Web of Science ®Google Scholar
• Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorders. Biol. Psychiatry60(2), 93–105 (2006).
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of OCD patients: on the trail of endophenotypes. Am. J. Psychiatry164(2), 335–338 (2006).
   Google Scholar
• Delorme R, Gousse V, Roy I et al. Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive–compulsive disorder. Eur. Psychiatry22(1), 32–38 (2007).
   PubMed Web of Science ®Google Scholar
• Menzies L, Williams GB, Chamberlain SR et al. White matter abnormalities in patients with obsessive–compulsive disorder and their first-degree relatives. Am. J. Psychiatry165(10), 1308–1315 (2008).
   PubMed Web of Science ®Google Scholar
• Hampshire A, Owen AM. Fractionating attentional control using event-related fMRI. Cereb. Cortex16(12), 1679–1689 (2006).
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Menzies L, Hampshire A et al. Orbitofrontal dysfunction in patients with obsessive–compulsive disorder and their unaffected relatives. Science321(5887), 421–422 (2008).
   PubMed Web of Science ®Google Scholar
• Mataix-Cols D, Wooderson S, Lawrence N et al. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive–compulsive disorder. Arch. Gen. Psychiatry61(6), 564–576 (2004).
   PubMed Web of Science ®Google Scholar
• Slaats-Willemse D, Swaab-Barneveld H, de Sonneville L, van der Meulen E, Buitelaar J. Deficient response inhibition as a cognitive endophenotype of ADHD. J. Am. Acad. Child Adolesc. Psychiatry42(10), 1242–1248 (2003).
   PubMed Web of Science ®Google Scholar
• Chamberlain SR, Fineberg NA, Menzies LA et al. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive–compulsive disorder. Am. J. Psychiatry164(2), 335–338 (2007).
   PubMed Web of Science ®Google Scholar
• Geller D, Petty C, Vivas F et al. Further evidence for cosegregation between pediatric obsessive compulsive disorder and attention deficit hyperactivity disorder: a familial risk analysis. Biol. Psychiatry61(12), 1388–1394 (2007).
   PubMedGoogle Scholar
• Geller D, Petty C, Vivas F et al. Examining the relationship between obsessive–compulsive disorder and attention-deficit/hyperactivity disorder in children and adolescents: a familial risk analysis. Biol. Psychiatry61(3), 316–321 (2007).
   PubMedGoogle Scholar
• van Grootheest DS, Boomsma DI, Hettema JM, Kendler KS. Heritability of obsessive–compulsive symptom dimensions. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(4), 473–478 (2008).
   PubMedGoogle Scholar
• Van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Genetic and environmental influences on obsessive–compulsive symptoms in adults: a population-based twin-family study. Psychol. Med.37(11), 1635–1644 (2007).
   PubMedGoogle Scholar
• Hollander E, Cohen LJ. Psychobiology and psychopharmacology of compulsive spectrum disorders. In: Impulsivity and Compulsivity. Oldham JM, Hollander E, Skodol AE (Eds). American Psychiatric Press Inc., WA, USA 143–164 (1996).
   Google Scholar
• Hollander E, Kim S, Khanna S, Pallanti S. Obsessive–compulsive disorder and obsessive–compulsive spectrum disorders: diagnostic and dimensional issues. CNS Spectr.12(2 Suppl. 3), 5–13 (2007).
   Web of Science ®Google Scholar
• Stein DJ, Hollander E. Obsessive–compulsive spectrum disorders. J. Clin. Psychiatry56(6), 265–266 (1995).
   PubMedGoogle Scholar